-
-
-
[1] 张声生,王宪波,江宇泳.肝硬化腹水中医诊疗专家共识意见(2017)[J].中华中医药杂志,2017,32(7):3065-3068.
[2] Chinese Society of Hepatology,Chinese Medical Association,Xu XY,et al.Chinese guidelines on the management of ascites and its related complications in cirrhosis[J].Hepatol Int,2019,13(1):1-21.
[3] 徐小元,丁惠国,李文刚,等.肝硬化腹水及相关并发症的诊疗指南[J].实用肝脏病杂志,2018,21(1):21-31.
[4] Naeem A,Jasbir M,Hafsa A,et al.Perioperative care of patients with liver cirrhosis:a review[J].Health Serv Insights,2017,10:1178632917691270.
[5] Brett F,Andres C.Ascites,Refractory Ascites and Hyponatremia in Cirrhosis[J].Gastroenterol Rep(Oxf),2017,5(2):104-112.
[6] Zhang K,Zhang YT,Li NN,et al.An herbal-compound-based combination therapy that relieves cirrhotic ascites by affecting the L-arginine/nitric oxide pathway:A metabolomics-based systematic study[J].JEthnopharmacol,2019,241:112034.
[7] 赵强,邢枫,刘成海.肝硬化腹水的中医药治疗研究进展[J].中华中医药杂志,2018,33(10):4557-4559.
[8] 郑保平,韩立民,刘海华,等.中医药治疗肝硬化腹水的组方用药规律分析[J].辽宁中医杂志,2018,45(2):233-236.
[9] 张瑞,曹庆伟,李爱平,等.基于网络药理学的黄芪抗疲劳作用机制研究[J].中草药,2019,50(8):1880-1889.
[10] 蒋华波,陆斌.鳖甲在抗肝纤维化和抗肝癌作用中的研究进展[J].基因组学与应用生物学,2017,36(4):1446-1450.
-
计量
- 文章访问数: 167
- PDF下载数: 366
- 施引文献: 0